IGHE and asthma: By definition patients who were enrolled with poorly controlled asthma tend to be those with T2 high disease in terms of having elevated levels of either eosinophils, FeNO and IgE at baseline, usually taking high dose ICS containing combination therapy as well as a requirement for maintenance oral corticosteroids (mOCS).